Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Sep 1:14:1210509.
doi: 10.3389/fphys.2023.1210509. eCollection 2023.

Platelet mitochondria, a potent immune mediator in neurological diseases

Affiliations
Review

Platelet mitochondria, a potent immune mediator in neurological diseases

Yan Ma et al. Front Physiol. .

Abstract

Dysfunction of the immune response is regarded as a prominent feature of neurological diseases, including neurodegenerative diseases, malignant tumors, acute neurotraumatic insult, and cerebral ischemic/hemorrhagic diseases. Platelets play a fundamental role in normal hemostasis and thrombosis. Beyond those normal functions, platelets are hyperactivated and contribute crucially to inflammation and immune responses in the central nervous system (CNS). Mitochondria are pivotal organelles in platelets and are responsible for generating most of the ATP that is used for platelet activation and aggregation (clumping). Notably, platelet mitochondria show marked morphological and functional alterations under heightened inflammatory/oxidative stimulation. Mitochondrial dysfunction not only leads to platelet damage and apoptosis but also further aggravates immune responses. Improving mitochondrial function is hopefully an effective strategy for treating neurological diseases. In this review, the authors discuss the immunomodulatory roles of platelet-derived mitochondria (PLT-mitos) in neurological diseases and summarize the neuroprotective effects of platelet mitochondria transplantation.

Keywords: central nervous system; mitochondria; neuroinflammation; platelet; transplantation.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Organelles of platelets and related products. Following activation, platelets show alterations of organelles. Some organelles, such as α-granules, dense granules, lysosomes, and mitochondria, contain multiple substances that can be released from activated platelets.
FIGURE 2
FIGURE 2
Mitochondrial biological functions in human diseases. Mitochondria affect multiple cellular processes, including inflammation, oxidative stress, autophagy, proliferation/viability, differentiation, necrosis/apoptosis/ferroptosis/pyroptosis/cuproptosis, angiogenesis, and neurogenesis. These cellular processes are closely related to human diseases, including neurological diseases.
FIGURE 3
FIGURE 3
Signaling pathways and proteins involved in mitochondria-mediated functions. Platelets become hyperactivated upon stimuli from blood under a pathological environment, are released from activated platelets, and act as a damage-associated molecular pattern (DAMP) to stimulate the innate immune system. Mitochondria can exert multiple functions, such as regulating apoptosis and ROS production.

Similar articles

Cited by

References

    1. Abdel-Rahman E. A., Zaky E. A., Aboulsaoud M., Elhossiny R. M., Youssef W. Y., Mahmoud A. M., et al. (2021). Autism spectrum disorder (ASD)-associated mitochondrial deficits are revealed in children's platelets but unimproved by hyperbaric oxygen therapy. Free Radic. Res. 55 (1), 26–40. 10.1080/10715762.2020.1856376 - DOI - PubMed
    1. Acquasaliente L., Pontarollo G., Radu C. M., Peterle D., Artusi I., Pagotto A., et al. (2022). Exogenous human α-Synuclein acts in vitro as a mild platelet antiaggregant inhibiting α-thrombin-induced platelet activation. Sci. Rep. 12 (1), 9880. Published 2022 Jun 14. 10.1038/s41598-022-12886-y - DOI - PMC - PubMed
    1. Aggarwal A., Jennings C. L., Manning E., Cameron S. J. (2023). Platelets at the vessel wall in non-thrombotic disease. Circ. Res. 132 (6), 775–790. 10.1161/CIRCRESAHA.122.321566 - DOI - PMC - PubMed
    1. Al Amir Dache Z., Otandault A., Tanos R., Pastor B., Meddeb R., Sanchez C., et al. (2020). Blood contains circulating cell-free respiratory competent mitochondria. FASEB J. 34 (3), 3616–3630. 10.1096/fj.201901917RR - DOI - PubMed
    1. Amorini A. M., Tuttobene M., Tomasello F. M., Biazzo F., Gullotta S., De Pinto V., et al. (2013). Glucose ameliorates the metabolic profile and mitochondrial function of platelet concentrates during storage in autologous plasma. Blood Transfus. 11 (1), 61–70. 10.2450/2012.0145-11 - DOI - PMC - PubMed

LinkOut - more resources